Introduction
Proton magnetic resonance spectroscopy ( 1 H-MRS) has offered the opportunity to noninvasively detect intraorgan lipids in nonadipose tissue, such as liver and muscle, so-called ectopic fat (1, 2) . In fact, after the introduction and the widespread use of this technique, evidence has accumulated that, in humans, increased intrahepatic lipid content (IHL content) is a very common condition, which strongly increases the risk to develop type 2 diabetes mellitus (T2DM) (3, 4) . Furthermore, a fatty liver also increases the risk for hypertriglyceridemia, cardiovascular disease, and nonalcoholic steatohepatitis (NASH) (5-7). Fatty liver disease is increasingly considered a major threat to metabolic health in overweight populations.
Despite the general appreciation of the unhealthy consequences of a fatty liver, the factors that contribute to hepatic fat accumulation in humans are still far from understood and mainly rely on studies performed in animal models. De novo lipogenesis, excessive (adipose tissue) lipolysis, and dietary fat retention are the pathways that contribute to liver fat, but their relative contribution in humans is still unknown. In fact, due to the lack of noninvasive methodologies, these pathways could so far only be estimated in patients scheduled for liver biopsies (8) and may therefore not necessarily reflect normal physiology. Clearly, tools are needed to investigate de novo lipogenesis, adipose tissue lipolysis, and dietary fat retention in human volunteers, including examining the effect of intervention studies.
Although 1 H-MRS can be used to measure total IHL content in vivo, this method does not yield information on the relative contribution of dietary fat retention to liver fat accumulation. As an alternative to magnetic resonance (MR), a fluorione-18 ( 
, can be used in humans to noninvasively determine organ-specific dietary fatty acid uptake after a meal (9) . However, next to the disadvantage of the exposure to radioactivity, the 18 FTHA tracer is trapped inside the hepatocyte upon entrance. Hence, this tracer only provides information on uptake. Here, we investigated
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the use of carbon-13-MRS ( 13 C-MRS) to study dietary fat uptake and retention in human liver. The low natural abundance of 13 C, and hence the low incorporation in endogenous lipids, makes 13 C-enriched fatty acids excellent candidates for in vivo MR tracer studies to study the uptake of dietary fat, metabolism, and net retention (10) . Classically, the use of 13 C-MRS, however, inherently suffers from low sensitivity when compared with 1 H-MRS. To overcome this problem of the relative low sensitivity of the 13 C nucleus, indirect detection techniques could be explored (11) . These techniques selectively detect protons, which are attached to a 13 C nucleus, via spectral editing; they thereby benefit from the enhanced sensitivity of the 1 H signal. Next to this increase in sensitivity, an additional advantage of these techniques is that standard 1 H localization techniques can be used, e.g. point resolved spectroscopy (PRESS) (12) and stimulated echo acquistion mode (STEAM) (13), to select a specified volume from which the signal is acquired.
Gradient enhanced heteronuclear multiple-quantum coherence spectroscopy (ge-HMQC) and gradient enhanced single-quantum coherence spectroscopy (ge-HSQC) allow the acquisition of (14) . Here, we investigated whether this special class of indirect detection methods, based on the indirect detection of single-quantum 13 C coherences, could be used to detect dietary fat retention in human liver. The large chemical shift of the 13 C resonances that contribute to the (A and B) In A, the results for the 1D ge-HMQC are shown, while in B, the outcome of the 1D ge-HSQC sequence is presented. The evolution time (t 1 ) was increased with 1 ms every step and started at, respectively, 7.6 and 4.2 ms. It is apparent that the signal acquired with the ge-HMQC decays rapidly with an increasing t 1 . lipid signal in the 1 H spectrum will lead to signal intensity loss and phase distortions when the conventional ge-HMQC and ge-HSQC sequences are applied as 1-dimensional (1D) editing techniques. In this study, we therefore compared 1D ge-HMQC and ge-HSQC sequences, which were specifically designed to refocus the chemical shift in the heteronuclear dimension. We compared the use of the 1D sequences for the detection of the 
Results
Phantom experiments. In Figure 1 , the spectra acquired from the Intralipid phantom with the conventional ge-HMQC and ge-HSQC ( C-enrichment -based on the CH 2 intensities -was also higher (0.72% with the ge-HMQC versus 0.93% with the ge-HSQC), indicating less signal loss with the ge-HSQC sequence, as this value is closer to the known natural abundance of 13 C isotopes of 1.1%. In contrast to the PRESS-based ge-HMQC sequence, the proton magnetization is along the longitudinal axis during the quantum coherence evolution period in the STEAM-based ge-HSQC sequence. To investigate the influence of passive 1 H-1 H couplings during the evolution time (t 1 ) period in the ge-HMQC, the t 1 evolution period was prolonged stepwise in the next experiment, which is shown in Figure 2 . The signal acquired with the 1D ge-HMQC sequence is rapidly decaying with a longer t 1 , while it is clearly visible that this decay is less pronounced when using the 1D ge-HSQC sequence, which already has an intrinsic shorter minimum t 1 .
For the in vivo measurements, increased local B 0 field variations in tissue are expected when compared with a homogeneous phantom. As these local inhomogeneities can counteract the effect of the applied gradients, stronger gradient dephasing is required. A longer t 1 period enables the use of gradients with a longer duration and, thus, a larger dephasing area. However, although the ge-HSQC sequence was shown to be insensitive toward 1 H-1 H couplings in the previous experiment with naturally abundance 13 C, the existence of 13 C- 13 C couplings in the uniformly labeled fatty acids should be taken into account. This was studied in a next experiment using a phantom with the tracer, which was identical to the tracer that was used for the human experiments, diluted in water. A stepwise increase of t 1 led to substantial signal loss, as measured by 1D ge-HSQC sequence (Figure 3) . In order to maximize the signal recovery, it is therefore imperative to minimize the t 1 evolution time.
In vivo experiments. All results of the in vivo experiments are displayed in Figure 4 . Typical examples of a total lipid spectrum ( 1 H-MRS) and its concomitant 13 C edited lipid spectrum acquired in the liver in vivo are shown (Figure 4 , A and B, respectively). Total IHL content in the liver at baseline was 11.3 ± 3.1 g/kg wet weight (ww) for the lean and 42.4 ± 13.1 g/kg ww for the obese subjects (P = 0.06). We did not observe significant changes in total IHL content upon meal consumption (P = 0.35 compared with baseline, Figure  4C ). 13 C lipid content in the liver did increase significantly in time after the meal (P < 0.01), but this increase was not significantly different between the groups (P = 0.29), as shown in Figure 4D . Absolute 13 C lipid concentrations increased from 0.12 ± 0.03 g/kg ww (1.1% of the total lipid content) at baseline to 0.19 ± 0.02 g/kg ww after 6 hours in the lean subjects. In the obese subjects, 13 C lipid content increased from 0.47 ± 0.14 g/kg ww at baseline to 0.62 ± 0.20 g/kg ww at 6 hours. Downloaded from http://insight.jci.org on July 9, 2017. https://doi.org/10.1172/jci.insight.84671
As the amount of tracer given was body mass dependent, the absolute concentrations were used to calculate the relative tracer retention in the liver after 6 hours. Tracer retention after 6 hours was similar in both groups (1.5% ± 0.7% and 1.6% ± 0.5% for lean and obese subjects respectively, P = 0.92, Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/jci.insight.84671DS1).
Discussion
Here, we have demonstrated the feasibility of tracking dietary fatty acids to the liver noninvasively in vivo with 1D ge-HSQC MRS to determine postprandial hepatic lipid retention. Importantly, this MRS-based approach can be performed taking advantage of 13 C as a naturally labeled stable isotope; hence, no radioactive tracers are required. The noninvasive measure of dietary fat uptake after a meal revealed that, in both lean and obese subjects, a substantial amount of dietary fat is retained in the liver. We anticipate that this method will permit noninvasive examination of whether and how postprandial fatty acid storage is affected in patients with a fatty liver and, importantly, also offers a way to discriminate the role of dietary fat retention versus de novo lipogenesis and excessive free fatty acids (FFA) lipolysis from adipose tissue. To date, these determinants could only be estimated by modeling approaches, in studies using multiple tracers and requiring liver biopsies (8), which is not feasible in larger intervention studies. Combining the MRS technique with accurate measures of total lipid content will give valuable insight into fat storage and oxidation -and, thus, turnover -of the IHL pool.
The use of quantum coherence spectroscopy techniques in vivo has not been fully explored in humans so far. In an attempt to optimize the measurement of postprandial lipid handling in the human liver in vivo Downloaded from http://insight.jci.org on July 9, 2017. https://doi.org/10.1172/jci.insight.84671 using a uniformly labeled 13 C fatty acid tracer, we have shown here that such techniques offer a robust alternative to subtraction-based J-editing sequences. As gradients are being used for clean coherence selection, quantum coherence sequences offer signals in a single shot, thereby omitting the need for subtraction and hence reducing motion artifacts. Phantom experiments revealed that the addition of 13 C inversion pulses to conventional 2D ge-HMQC and ge-HSQC sequences is essential in order to obtain 1 H-[ 13 C]-lipid signals in a 1D spectrum without phase distortions. The higher signal-to-noise ratio (SNR), as obtained with the 1D approach, now offers the opportunity to quantitatively study the dynamic incorporation of meal-derived 13 C lipid tracer into the IHL pool in vivo on a 3T clinical scanner. As 1 H-1 H coupling evolution is absent in the t 1 period in the ge-HSQC, this sequence yields higher signals when compared with the ge-HMQC.
Previously, direct 13 C-MRS was explored to investigate dietary fat retention in humans (10) . The intrinsically low sensitivity and the large chemical shift dispersion, as encountered in direct 13 C-MRS, forced the researchers to perform unlocalized measurements. It was reported that approximately 9% of the ingested 13 C tracer was stored in the liver of control subjects at the peak uptake after 6 hours; however, these measurements were performed unlocalized. These numbers are higher than what we report here, but contaminating signals from adipose tissue -as well as from 13 C tracer in the stomach and intestine -are likely to affect these measurements and will result in higher uptake levels if unlocalized measurements are performed. Considering the amount of tracer used, the low sensitivity of the direct 13 C approach and the limited amount of tracer stored in the liver as indicated by our results further suggest that the successful detection of differences in 13 C enrichment in the IHL pool using direct 13 C-MRS is extremely challenging, if not impossible.
Heteronuclear quantum coherence spectroscopy can be seen as a special class of indirect spectroscopy techniques. Indirect ] signals, it is prone to motion-induced subtraction artifacts, and that becomes a major problem in motion-sensitive tissue such as the liver in humans. In rats measured under anesthesia, motion artifacts due to breathing were absent (17) , but initial human experiments in our lab using the same POCE methodology on a clinical 3T scanner indeed revealed that subtraction artifacts as a result of motion posed an insurmountable problem for accurate and robust detection of (data not shown) . Therefore, we concluded that the POCE methodology does not lead to a robust and accurate measure of the naturally abundant 13 C signal in humans. The 1D ge-HSQC sequence offers a quarter of the maximal theoretical signal when compared with the described methodology in rats, which is a result of the use of STEAM localization and gradient coherence selection. In practice, these differences are much smaller, as the STEAM localization sequence has an intrinsically shorter echo time (TE), and furthermore, the robustness of spoiling the large In the present study, the use of both the 1D ge-HMQC and the 1D ge-HSQC was investigated. Identical to the above described reasoning, the intrinsic TE in the 1D ge-HSQC is shorter than in the 1D ge-HMQC. In practice, the reference signals acquired with both of these sequences were (almost) equal, showing that the theoretical 50% signal loss in STEAM spectroscopy was balanced by the longer TE due to PRESS localization in the currently compared protocols. Apart from the localization technique, the sequences differ in the quantum coherence evolution period. During the t 1 period in the ge-HMQC, both ]-lipid signal is rapidly decaying with increased t 1 in the 1D ge-HMQC. This strong signal decay was absent in the 1D ge-HSQC. As a larger number of radio frequency (RF) pulses was required to fully refocus 13 C chemical shift evolution in the 1D ge-HMQC, the minimum t 1 was already increased when compared with the 1D ge-HSQC. On top of that, a larger number of RF pulses also induced increased signal losses as a consequence of (small) miscalibrations. Taken together, we concluded that the 1D ge-HSQC sequence yields higher absolute signals and also higher (relative) 13 C-enrichment and is therefore the superior technique for in vivo 13 C fatty acid tracking. As mentioned, 13 C- 13 C couplings do evolve during the quantum coherence evolution period in the 1D ge-HSQC. In nature, only 1.1% of all carbon nuclei is present as 13 C isotope, which reduces the chance that two 13 C nuclei are directly adjacent virtually to 0. Therefore, signal losses due to 13 C- 13 C couplings are negligible when applied to molecules with naturally abundant 13 C. This situation, however, changes in the case of the uniformly labeled 13 C tracer, as we used in the present study, where 13 C nuclei are indeed adjacent to each other. As shown in a phantom experiment with the uniformly labeled tracer, the ge-HSQC signal decreases considerably with increasing t 1 , indicating signal losses due to 13 C- 13 C couplings. As longer gradients are preferred to completely dephase all residual signals in vivo, a longer t 1 can be chosen when one is interested in 13 C natural abundance only. When uniformly labeled tracers are used, however, short t 1 are required and the t 1 of 6.1 ms chosen in this study ensured only minor signal losses due to C enrichment after the meal was not corrected for signal losses due to 13 C- 13 C couplings, which might lead to a small underestimation of tracer uptake.
The described 1D ge-HSQC methodology was applied to measure the storage of 13 C-labeled dietary fatty acids in the liver in vivo and was used to quantify the amount of lipids stored from a single meal. We indeed were able to measure a significant increase in 13 C lipid content in the liver in both lean and obese subjects, reflecting incorporation of dietary lipids into hepatic liver fat. It is important to note that, with 1 H-MRS, we are not able to detect any changes in the total IHL content upon the consumption of a meal with the current protocol. This inability is most likely attributed to a lack in sensitivity to detect the very small changes with respect to the large background signal ( C tracer approach to allow the detection of nutritional effects on liver fat accumulation Approximately 1.5% of the orally administered tracer could be detected in the liver 6 hours after the meal, and this calculated tracer retention was similar for lean and obese subjects. Although the retention of 1.5% may seem small, it should be considered that a daily intake of 100 grams of fat, spread over 3 meals, is normal for humans consuming a Western diet, suggesting that 1.5 grams of dietary fat could end up in the liver. For a healthy subject with a relatively low liver-fat percentage of 1%, which equals approximately 15 g of total hepatic lipid, dietary fat could therefore make up around 10% of the total IHL pool over a day. This is in close agreement with estimations (~15%) from the aforementioned study by Donnelly et al., who used liver biopsies (8) . This thus suggests that liver fat turnover is high and that the contribution of dietary fat is physiologically relevant. Furthermore, considering that dietary fat retention did not return to premeal levels within 6 hours and meal intervals during the day are around 4-5 hours, these data suggest that dietary fatty acid intake can lead to substantial increases in total liver fat concentrations, hence leading to the development from a healthy to a fatty liver. Therefore, strategies to influence the storage of dietary fat into the liver may be an effective tool to prevent hepatic steatosis.
To conclude, we have shown here that we were able to acquire 1D 13 C-edited spectra in a single shot by using 13 C inversion pulses in the quantum coherence evolution period of a ge-HSQC sequence. The 1D ge-HSQC sequence was applied in vivo, and postprandial handling of dietary fatty acids in the liver could be followed dynamically. This technique allows the performance of in vivo studies to investigate the role of postprandial fatty acid handling in both healthy subjects and subjects at risk for increased liver fat. Additional studies using this noninvasive tool can give insight into how to influence dietary fat retention, for example by varying meal timing and composition, to prevent excessive lipid storage in the liver.
Methods

MR Sequences and equipment
Experiments were performed on a 3T clinical MR system (Achieva 3T-X, Philips Healthcare) using a butterfly-loop 1 H transmit/receive quadrature coil combined with two 16-cm 13 C transmit/receive surface coils in quadrature-mode for optimal 1 H receiving sensitivity (Rapid Biomedical GmbH). The 2-pulse sequences that have been compared in this study are displayed in Figure 5 . While in conventional 2D ge-HMQC and ge-HSQC sequences, the chemical shift of the heteronucleus and determines the acquired phase in the quantum coherence t 1 , this frequency-dependent phase modulation is unwanted in 1D spectroscopy because of signal intensity losses and phase distortions in the 
1D ge-HMQC
The 1D ge-HMQC sequence starts with conventional PRESS localization, which is followed by a time delay of 1/2J CH (3.95 ms for lipid CH 2 ) to produce nonobservable antiphase magnetization for the protons attached to a 13 C nucleus (18) . The first 90° pulse on the 13 C channel then generates zero and double quantum coherences (ZQC and DQC, respectively). For the highlighted coherence pathway in Figure  1A , the DQCs are converted to ZQCs by the first 13 C 180° RF pulse, then converted back to DQC again by the 1 H 180° pulse, followed by another conversion to ZQCs by the second 13 C 180° pulse. The last 90° 13 C pulse converts the coherence states back to antiphase magnetization, which evolves to observable transverse magnetization after the 1/2J CH delay. The symmetric sequence created not only refocuses 13 C chemical shift evolution, but also prevents the B 0 inhomogeneity-induced delayed echo formation of the 1 H-[
13 C] signal (19) . Due to the creation of four different coherence states during the t 1 , 5 instead of 3 are applied to achieve coherence selection. A gradient ratio of G1:G2:G3:G4:G5 = 1:1:-1:-1:1.006 was used for selection of the multiple quantum coherences. Because all gradients can be of equal strength, the maximal gradient strength is used to efficiently dephase all unwanted coherences. Gradients (30 mT/m) of equal duration (1.0 ms) were applied in the Z direction only. The 13 C RF pulses were all played out as hard pulses with a duration of 0.34 ms (90°) and 0.67 ms (180°) respectively. Duration of the Gaussian shaped 1 H 180° RF pulse was 1.09 ms. This led to a minimum t 1 of 7.6 ms. The first 13 C pulse was phase cycled to improve spoiling of unwanted coherences, and the offset of the 13 C pulses was set at the midchain 13 C-CH 2 resonance (~29 ppm). To minimize the total TE, the PRESS spoiler gradient areas were chosen in a ratio of 1:-1:1:3, with the largest gradient placed in the last 1/2J CH delay. The total TE of the sequence was 28.9 ms.
1D ge-HSQC
STEAM localization lies at the basis of the 1D ge-HSQC sequence ( Figure 1B) , as was reported previously (19, 20) . The delay of 1/2J CH after the 1 H excitation RF pulse leads to antiphase magnetization of the protons attached to a 13 C nucleus. The second 1 H 90° RF pulse converts the transversal antiphase magnetization into longitudinal magnetization. During the TM, a hard 13 C 90° RF pulse results in the formation of a single quantum coherence state, which will evolve based on the 13 C resonance frequency. A next hard 13 C 180° RF pulse, which is placed exactly in the middle of the t 1 , changes the sign of the coherence order (from +1 to -1). A final hard 13 C 90° RF pulse again creates longitudinal antiphase magnetization. A crusher gradient (duration of 4.44 ms, strength 30 mT/m) is used in the TM period prior to the 13 C 90° RF pulses to dephase any existing transversal magnetization. The third and final 1 H 90° RF pulse flips back the longitudinal magnetization to the transversal plane, which will then generate an observable echo after another delay of 1/2J CH . Gradients were used in the ratio of G1:G2:G3 = 2:-2:1.006. At this point, only 50% of the maximal available gradient strength could be used for dephasing of the unwanted coherences. The strength of the gradients in the t 1 period was 30 mT/m, and the gradient in the refocusing period was set to 15.087 mT/m. These coherence selection gradients were applied in the Z direction. For the phantom experiments, the duration of these gradients was set to 1.5 ms, while for the in vivo experiments, the gradients were lengthened to 2.5 ms. As for the ge-HMQC, the length of the 13 C RF pulses was 0.34 ms for the 90° and 0.67 ms for the 180° pulse, and the pulses where applied with an offset around 29 ppm. The minimum t 1 was 4.2 ms for the phantom experiments and 6.1 ms for the in vivo experiments. The TM period was 22.6 ms and 24.5 ms, respectively, while total TE of the sequence was, by definition, equal to 1/J CH (7.9 ms for the lipid CH 2 resonance).
For the phantom experiments, where the ge-HMQC and ge-HSQC methods were compared, phase cycling of the ge-HSQC was identical to the ge-HMQC sequence. Hence, the phase of the first 13 C pulse (x, -x) and the acquisition channel (x, -x) were cycled. As the phantom experiment showed that the 1D ge-HSQC sequence was superior for the current aim, only the 1D ge-HSQC sequence was applied in the in vivo experiments. To further improve the spoiling of unwanted echoes in the in vivo experiments, additional phase cycling was applied to the proton excitation pulse and the second 13 C pulse of the HSQC block (16 steps phase cyling).
Phantom experiments
Phantoms. In this study, phantom experiments were performed for two different purposes. In the first experiments, the signal intensities of the 1D ge-HMQC and the 1D ge-HSQC sequence were compared on a 500-ml phantom filled with 20% Intralipid (Fresenius Kabi Global), a stable fat emulsion of fine droplets of soybean oil. Identical to the situation in vivo, 1.1% of all carbon nuclei are 13 C isotopes (natural abundance). In a subsequent experiment, a spherical phantom with uniformly 13 C-labeled algal lipids (1.5 g) dissolved in water was used ( >98% 13 C; 53% palmitic acid, 28% oleic acid, 9% palmitioleic acid, and 6% linoleic acid; Cambridge Isotopes Laboratories Inc.). Here, the influence of the 13 C- 13 C couplings in the uniformly labeled fatty acid tracer was tested by increasing the t 1 of the 1D ge-HSQC sequence. The same algal lipid mixture was used for the in vivo experiments.
MR spectroscopy. Scout images were acquired to enable placement of a voxel of 20 × 40 × 40 mm in the center of the phantom. The threshold ratio (TR) of all experiments was set to 2,000 ms, and spectra were acquired with a bandwidth of 2,000 Hz (1,024 data points). Both the 1 H and the 13 C pulses were calibrated by measuring a single slice with a varying flip angle. Lipid reference signals were obtained by turning off the coherence selection gradients and by setting the frequency of the 13 C RF pulses far off resonance. Shimming was performed using second order FASTMAP-based shimming (21) .
First, spectra were acquired with both the conventional ge-HMQC and ge-HSQC sequence -without the added 13 C 180° pulses (number of spectral acquisitions [NSA] = 128). In a next experiment, the principle of the 1D sequences was tested by now turning on these 13 C 180° pulses. This also allowed comparison between the signal intensities of the 1D ge-HMQC and the 1D ge-HSQC sequence. We also tested the effect of an increased t 1 in both sequences by measuring 25 spectra with a stepwise increasing t 1 . The starting t 1 was set to the minimum possible (7.6 and 4.2 ms, respectively), and t 1 was increased with 1 ms per spectrum. Each spectrum consisted of 8 averaged acquisitions.
As the 13 C nuclei are directly adjacent to each other in the uniformly 13 C-labeled fatty acids, additional signal losses during t 1 are expected due to (strong) 13 C- 13 C scalar couplings. To be able to choose the approDownloaded from http://insight.jci.org on July 9, 2017. https://doi.org/10.1172/jci.insight.84671 priate t 1 for the in vivo experiments, an identical experiment with a series of spectra with increasing t 1 , as was performed on the Intralipid, was also performed on the algal lipid mixture phantom. This last experiment was only done with the 1D ge-HSQC sequence.
Data analysis. All spectra were analyzed and fitted in the time domain by using the nonlinear leastsquares AMARES algorithm in the jMRUI software package (22) . Spectra were apodized with a 5 Hz Gaussian lineshape. The CH 2 peaks of the lipid signal were fitted with a Gaussian lineshape. Because no decoupling was applied, 2 peaks of equal amplitude and with equal line width were fitted for the 13 C-edited spectra. The 13 C-enrichment was calculated by dividing the sum of the area of the 2 peaks in the edited spectra with the area under the peak in the reference spectra. A correction factor of 2 was applied to correct for the intrinsic 50% signal loss as encountered due to the coherence gradient selection.
In vivo experiments
Subjects. To validate our methodology in humans in vivo, we included 5 lean (2 female/3 male, age 49 ± 13 years, and BMI 22 ± 3 kg/m 2 ) and 6 obese (3 female/3 male, age 52 ± 10 years, and BMI 31 ± 6 kg/m 2 ) subjects. All subjects were considered healthy and weight stable (fluctuations in body mass < 3 kg) for at least 6 months prior to the study.
Study protocol. On the test day, the subjects arrived at the university at 7 am after an overnight fast. Two days prior to the test days, subjects were asked to refrain from strenuous physical activity and to consume their habitual diet. After the baseline MRS measurement, subjects consumed a high-fat (60E% fat, 36E% carbohydrates and 4E% protein) liquid meal, with a total energy content of 753 kcal and fat content of 50.3 g. On top of this, the subject consumed capsules containing 0.1 g/kg body weight of the U- 13 C algal lipid mixture. The algal lipid mixture was tested and packaged for oral intake by the clinical pharmacy of the Radboud University Medical Center (Nijmegen, The Netherlands). Subjects drank water ad libitum during the test day. Following on from the liquid meal with tracer, MRS measurements were performed after 1.5, 3.0, 4.5, and 6.0 hours to measure the 13 C enrichment in the IHL pool. MR Spectroscopy. Subjects were positioned in the MRI scanner in supine position and head first. The surface coil was placed over the right hypochondrium and was positioned to ensure that the liver was in the region of the sensitivity of the coil, which was verified with MR imaging. Scout images were acquired prior to the MR spectroscopy protocol, to accurately position the voxel of 40 × 60 × 60 mm inside the liver. Special care was taken to ensure that the voxel was positioned at the very same location during the repeated measurements. A pressure-sensitive sensor was used to keep track of the breathing rhythm and to gate the acquisition of the spectra. Start of the spectroscopy sequence was adjusted per subject and was between 1,000 and 1,500 ms after the top of inspiration.
After placement of the voxel, the 1 H pulse angle was calibrated with a standard available algorithm on the Philips MR scanner. Based on the 1 H settings, the 13 C pulse angle was calibrated according to a calibration curve, which was measured in a phantom beforehand. Following the calibration of the pulses, second-order FASTMAP shimming was performed.
Then, water (NSA = 32) and lipid reference signals (NSA = 64) were acquired by turning off the coherence selection gradients and by setting the frequency of the 13 C RF pulses far off resonance. For the lipid reference spectrum, the water peak was suppressed using a frequency-selective adiabatic inversion pulse, played out 300 ms prior to the excitation pulse. The 1D ge-HSQC sequence was started successively. A total of 320 individual acquisitions was averaged to come to the 13 C-edited lipid spectrum. Total duration of the in vivo protocol was approximately 45 minutes.
Data analysis. Baseline IHL content was calculated from the water and lipid spectra after individual phasing of the individual spectra. For one of the obese subjects, data from the time point at 6.0 hours was excluded due to insufficient quality of the spectra. All spectra were fitted in jMRUI software using Gaussian line shapes. For the 13 C edited spectra, the fitting procedure was identical to the procedures described for the phantom experiments. The ratio of the line width of the 2 peaks in the edited spectra and the line width of the peak in the lipid reference scan were kept constant for the repeated measurement in one subject.
Both total fat content, as determined with 1 H-MRS, and 13 C fat content, as determined with ge-HSQC, are expressed in absolute concentrations (in g/kg wet weight) using water as the internal reference and based on previously published assumptions on water content and relaxation times (1, 23) . As the amount of tracer consumed was different between subjects (based on the body weight of the subject), tracer retention was calculated as a percentage of the total intake of tracer. An average liver mass of 1.5 kg was used (24) for these calculations. For the in vivo experiments, repeated-measures ANOVA was performed to test for differences in total lipid and 13 C lipid content in the liver. A 2-tailed independent samples Student t test was performed to test for differences in tracer uptake (in % of total dose) between groups. A P value less than 0.05 was considered to be statistically significant for all tests.
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